What is Refocus Group, Inc. (RFCS)?

Refocus Group, Inc. (RFCS) is a stock in the Healthcare sector, Medical - Devices industry. View full analysis on Stocks360.

What is the current price of RFCS?

The current price of RFCS is $0.00. Prices are updated in real time on Stocks360.

What is RFCS's market capitalization?

RFCS's market capitalization is $25.00, placing it in the small-cap tier.

Refocus Group, Inc. (RFCS)

Stock analysis · OTC · Healthcare · Medical - Devices

$0.00

Market Cap

$25.00

PE (TTM)

N/A

EPS (TTM)

N/A

Dividend Yield

N/A

Beta

-0.58

Day Range

$0.00 – $0.00

52-wk Range

$0.00 – $0.00

Avg Volume

N/A

Volume

47.40K

Refocus Group, Inc. (RFCS) is a publicly traded company in the Healthcare sector. Latest price: $0.00. Market cap $25.00. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

Proprietary Signals

Signal snapshot temporarily unavailable.

About Refocus Group, Inc.

Refocus Group, Inc. is a medical technology firm dedicated to the research and creation of therapies for various human vision conditions, particularly presbyopia. A key offering is the VisAbility Micro-Insert System, an experimental medical device currently undergoing clinical evaluations for its application in treating presbyopia affecting both eyes. The organization caters to the needs of both patients and ophthalmic professionals. Founded in 1994, this company operates from its base in Dallas, Texas.